nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxylamine—Benzphetamine—POR—urinary bladder cancer	0.00888	0.482	CrCbGaD
Doxylamine—Toremifene—ESR1—urinary bladder cancer	0.00466	0.253	CrCbGaD
Doxylamine—Tamoxifen—ESR2—urinary bladder cancer	0.00302	0.164	CrCbGaD
Doxylamine—Nervous system disorder—Cisplatin—urinary bladder cancer	0.00197	0.00201	CcSEcCtD
Doxylamine—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00197	0.002	CcSEcCtD
Doxylamine—Tachycardia—Cisplatin—urinary bladder cancer	0.00196	0.002	CcSEcCtD
Doxylamine—Convulsion—Etoposide—urinary bladder cancer	0.00195	0.00199	CcSEcCtD
Doxylamine—Dehydration—Epirubicin—urinary bladder cancer	0.00195	0.00199	CcSEcCtD
Doxylamine—Insomnia—Gemcitabine—urinary bladder cancer	0.00195	0.00199	CcSEcCtD
Doxylamine—Diplopia—Doxorubicin—urinary bladder cancer	0.00194	0.00198	CcSEcCtD
Doxylamine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00194	0.00198	CcSEcCtD
Doxylamine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00192	0.00196	CcSEcCtD
Doxylamine—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.00192	0.00195	CcSEcCtD
Doxylamine—Insomnia—Fluorouracil—urinary bladder cancer	0.00192	0.00195	CcSEcCtD
Doxylamine—Somnolence—Gemcitabine—urinary bladder cancer	0.00192	0.00195	CcSEcCtD
Doxylamine—Anorexia—Cisplatin—urinary bladder cancer	0.00191	0.00195	CcSEcCtD
Doxylamine—Affect lability—Doxorubicin—urinary bladder cancer	0.00191	0.00195	CcSEcCtD
Doxylamine—Pancreatitis—Methotrexate—urinary bladder cancer	0.0019	0.00194	CcSEcCtD
Doxylamine—Discomfort—Etoposide—urinary bladder cancer	0.0019	0.00193	CcSEcCtD
Doxylamine—Breast disorder—Epirubicin—urinary bladder cancer	0.0019	0.00193	CcSEcCtD
Doxylamine—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.00189	0.00193	CcSEcCtD
Doxylamine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00189	0.00192	CcSEcCtD
Doxylamine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00189	0.00192	CcSEcCtD
Doxylamine—Somnolence—Fluorouracil—urinary bladder cancer	0.00188	0.00192	CcSEcCtD
Doxylamine—Hypotension—Cisplatin—urinary bladder cancer	0.00188	0.00191	CcSEcCtD
Doxylamine—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.00188	0.00191	CcSEcCtD
Doxylamine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00187	0.00191	CcSEcCtD
Doxylamine—Tamoxifen—ESR1—urinary bladder cancer	0.00186	0.101	CrCbGaD
Doxylamine—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00186	0.0019	CcSEcCtD
Doxylamine—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.00186	0.00189	CcSEcCtD
Doxylamine—Fatigue—Gemcitabine—urinary bladder cancer	0.00186	0.00189	CcSEcCtD
Doxylamine—Confusional state—Etoposide—urinary bladder cancer	0.00186	0.00189	CcSEcCtD
Doxylamine—Constipation—Gemcitabine—urinary bladder cancer	0.00184	0.00188	CcSEcCtD
Doxylamine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00184	0.00188	CcSEcCtD
Doxylamine—Pancytopenia—Methotrexate—urinary bladder cancer	0.00184	0.00188	CcSEcCtD
Doxylamine—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00184	0.00187	CcSEcCtD
Doxylamine—Mood swings—Doxorubicin—urinary bladder cancer	0.00184	0.00187	CcSEcCtD
Doxylamine—Asthenia—Thiotepa—urinary bladder cancer	0.00184	0.00187	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00183	0.00186	CcSEcCtD
Doxylamine—Pruritus—Thiotepa—urinary bladder cancer	0.00181	0.00185	CcSEcCtD
Doxylamine—Dehydration—Doxorubicin—urinary bladder cancer	0.00181	0.00184	CcSEcCtD
Doxylamine—Thrombocytopenia—Etoposide—urinary bladder cancer	0.0018	0.00184	CcSEcCtD
Doxylamine—Tachycardia—Etoposide—urinary bladder cancer	0.0018	0.00183	CcSEcCtD
Doxylamine—Dyspnoea—Cisplatin—urinary bladder cancer	0.00179	0.00182	CcSEcCtD
Doxylamine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00178	0.00181	CcSEcCtD
Doxylamine—Pancreatitis—Epirubicin—urinary bladder cancer	0.00178	0.00181	CcSEcCtD
Doxylamine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00178	0.00181	CcSEcCtD
Doxylamine—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.00177	0.00181	CcSEcCtD
Doxylamine—Breast disorder—Doxorubicin—urinary bladder cancer	0.00175	0.00179	CcSEcCtD
Doxylamine—Anorexia—Etoposide—urinary bladder cancer	0.00175	0.00179	CcSEcCtD
Doxylamine—Diarrhoea—Thiotepa—urinary bladder cancer	0.00175	0.00179	CcSEcCtD
Doxylamine—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.00175	0.00178	CcSEcCtD
Doxylamine—Decreased appetite—Cisplatin—urinary bladder cancer	0.00175	0.00178	CcSEcCtD
Doxylamine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00175	0.00178	CcSEcCtD
Doxylamine—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.00174	0.00177	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00173	0.00177	CcSEcCtD
Doxylamine—Drowsiness—Methotrexate—urinary bladder cancer	0.00173	0.00176	CcSEcCtD
Doxylamine—Depression—Methotrexate—urinary bladder cancer	0.00172	0.00176	CcSEcCtD
Doxylamine—Pancytopenia—Epirubicin—urinary bladder cancer	0.00172	0.00175	CcSEcCtD
Doxylamine—Hypotension—Etoposide—urinary bladder cancer	0.00172	0.00175	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.00171	0.00175	CcSEcCtD
Doxylamine—Dizziness—Thiotepa—urinary bladder cancer	0.00169	0.00173	CcSEcCtD
Doxylamine—Urticaria—Fluorouracil—urinary bladder cancer	0.00168	0.00171	CcSEcCtD
Doxylamine—Sweating—Methotrexate—urinary bladder cancer	0.00166	0.00169	CcSEcCtD
Doxylamine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00166	0.00169	CcSEcCtD
Doxylamine—Pancreatitis—Doxorubicin—urinary bladder cancer	0.00165	0.00168	CcSEcCtD
Doxylamine—Dyspnoea—Etoposide—urinary bladder cancer	0.00164	0.00167	CcSEcCtD
Doxylamine—Somnolence—Etoposide—urinary bladder cancer	0.00164	0.00167	CcSEcCtD
Doxylamine—Vomiting—Thiotepa—urinary bladder cancer	0.00163	0.00166	CcSEcCtD
Doxylamine—Drowsiness—Epirubicin—urinary bladder cancer	0.00162	0.00165	CcSEcCtD
Doxylamine—Rash—Thiotepa—urinary bladder cancer	0.00162	0.00165	CcSEcCtD
Doxylamine—Dermatitis—Thiotepa—urinary bladder cancer	0.00161	0.00164	CcSEcCtD
Doxylamine—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00161	0.00164	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.0016	0.00163	CcSEcCtD
Doxylamine—Decreased appetite—Etoposide—urinary bladder cancer	0.0016	0.00163	CcSEcCtD
Doxylamine—Pancytopenia—Doxorubicin—urinary bladder cancer	0.00159	0.00162	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00159	0.00162	CcSEcCtD
Doxylamine—Fatigue—Etoposide—urinary bladder cancer	0.00159	0.00162	CcSEcCtD
Doxylamine—Constipation—Etoposide—urinary bladder cancer	0.00157	0.0016	CcSEcCtD
Doxylamine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00156	0.00159	CcSEcCtD
Doxylamine—Hepatitis—Methotrexate—urinary bladder cancer	0.00155	0.00158	CcSEcCtD
Doxylamine—Sweating—Epirubicin—urinary bladder cancer	0.00155	0.00158	CcSEcCtD
Doxylamine—Asthenia—Gemcitabine—urinary bladder cancer	0.00155	0.00157	CcSEcCtD
Doxylamine—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.00153	0.00156	CcSEcCtD
Doxylamine—Pruritus—Gemcitabine—urinary bladder cancer	0.00152	0.00155	CcSEcCtD
Doxylamine—Nausea—Thiotepa—urinary bladder cancer	0.00152	0.00155	CcSEcCtD
Doxylamine—Urethral disorder—Methotrexate—urinary bladder cancer	0.00152	0.00155	CcSEcCtD
Doxylamine—Feeling abnormal—Etoposide—urinary bladder cancer	0.00152	0.00154	CcSEcCtD
Doxylamine—Agranulocytosis—Epirubicin—urinary bladder cancer	0.00151	0.00154	CcSEcCtD
Doxylamine—Pruritus—Fluorouracil—urinary bladder cancer	0.0015	0.00153	CcSEcCtD
Doxylamine—Drowsiness—Doxorubicin—urinary bladder cancer	0.0015	0.00152	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.00148	0.00151	CcSEcCtD
Doxylamine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00148	0.00151	CcSEcCtD
Doxylamine—Bradycardia—Epirubicin—urinary bladder cancer	0.00148	0.00151	CcSEcCtD
Doxylamine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00147	0.0015	CcSEcCtD
Doxylamine—Erythema multiforme—Methotrexate—urinary bladder cancer	0.00147	0.00149	CcSEcCtD
Doxylamine—Urticaria—Etoposide—urinary bladder cancer	0.00146	0.00149	CcSEcCtD
Doxylamine—Hepatitis—Epirubicin—urinary bladder cancer	0.00145	0.00148	CcSEcCtD
Doxylamine—Eye disorder—Methotrexate—urinary bladder cancer	0.00145	0.00148	CcSEcCtD
Doxylamine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00145	0.00148	CcSEcCtD
Doxylamine—Asthenia—Cisplatin—urinary bladder cancer	0.00144	0.00147	CcSEcCtD
Doxylamine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.00144	0.00147	CcSEcCtD
Doxylamine—Sweating—Doxorubicin—urinary bladder cancer	0.00143	0.00146	CcSEcCtD
Doxylamine—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.00143	0.00146	CcSEcCtD
Doxylamine—Urethral disorder—Epirubicin—urinary bladder cancer	0.00142	0.00145	CcSEcCtD
Doxylamine—Immune system disorder—Methotrexate—urinary bladder cancer	0.0014	0.00143	CcSEcCtD
Doxylamine—Dizziness—Fluorouracil—urinary bladder cancer	0.0014	0.00143	CcSEcCtD
Doxylamine—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.0014	0.00142	CcSEcCtD
Doxylamine—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.0014	0.00142	CcSEcCtD
Doxylamine—Diarrhoea—Cisplatin—urinary bladder cancer	0.00137	0.0014	CcSEcCtD
Doxylamine—Erythema multiforme—Epirubicin—urinary bladder cancer	0.00137	0.0014	CcSEcCtD
Doxylamine—Vomiting—Gemcitabine—urinary bladder cancer	0.00137	0.0014	CcSEcCtD
Doxylamine—Bradycardia—Doxorubicin—urinary bladder cancer	0.00137	0.00139	CcSEcCtD
Doxylamine—Rash—Gemcitabine—urinary bladder cancer	0.00136	0.00138	CcSEcCtD
Doxylamine—Dermatitis—Gemcitabine—urinary bladder cancer	0.00136	0.00138	CcSEcCtD
Doxylamine—Eye disorder—Epirubicin—urinary bladder cancer	0.00136	0.00138	CcSEcCtD
Doxylamine—Hypersensitivity—Etoposide—urinary bladder cancer	0.00136	0.00138	CcSEcCtD
Doxylamine—Erythema—Methotrexate—urinary bladder cancer	0.00135	0.00138	CcSEcCtD
Doxylamine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.00135	0.00137	CcSEcCtD
Doxylamine—Flushing—Epirubicin—urinary bladder cancer	0.00135	0.00137	CcSEcCtD
Doxylamine—Vomiting—Fluorouracil—urinary bladder cancer	0.00135	0.00137	CcSEcCtD
Doxylamine—Hepatitis—Doxorubicin—urinary bladder cancer	0.00134	0.00137	CcSEcCtD
Doxylamine—Rash—Fluorouracil—urinary bladder cancer	0.00134	0.00136	CcSEcCtD
Doxylamine—Dermatitis—Fluorouracil—urinary bladder cancer	0.00133	0.00136	CcSEcCtD
Doxylamine—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.00133	0.00135	CcSEcCtD
Doxylamine—Asthenia—Etoposide—urinary bladder cancer	0.00132	0.00134	CcSEcCtD
Doxylamine—Urethral disorder—Doxorubicin—urinary bladder cancer	0.00132	0.00134	CcSEcCtD
Doxylamine—Immune system disorder—Epirubicin—urinary bladder cancer	0.00131	0.00134	CcSEcCtD
Doxylamine—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.00131	0.00133	CcSEcCtD
Doxylamine—Pruritus—Etoposide—urinary bladder cancer	0.0013	0.00133	CcSEcCtD
Doxylamine—Nausea—Gemcitabine—urinary bladder cancer	0.00128	0.0013	CcSEcCtD
Doxylamine—Vomiting—Cisplatin—urinary bladder cancer	0.00128	0.0013	CcSEcCtD
Doxylamine—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.00127	0.00129	CcSEcCtD
Doxylamine—Rash—Cisplatin—urinary bladder cancer	0.00127	0.00129	CcSEcCtD
Doxylamine—Dermatitis—Cisplatin—urinary bladder cancer	0.00127	0.00129	CcSEcCtD
Doxylamine—Erythema—Epirubicin—urinary bladder cancer	0.00126	0.00129	CcSEcCtD
Doxylamine—Diarrhoea—Etoposide—urinary bladder cancer	0.00126	0.00128	CcSEcCtD
Doxylamine—Nausea—Fluorouracil—urinary bladder cancer	0.00126	0.00128	CcSEcCtD
Doxylamine—Eye disorder—Doxorubicin—urinary bladder cancer	0.00126	0.00128	CcSEcCtD
Doxylamine—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.00125	0.00128	CcSEcCtD
Doxylamine—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.00125	0.00127	CcSEcCtD
Doxylamine—Flushing—Doxorubicin—urinary bladder cancer	0.00125	0.00127	CcSEcCtD
Doxylamine—Malaise—Methotrexate—urinary bladder cancer	0.00122	0.00124	CcSEcCtD
Doxylamine—Dizziness—Etoposide—urinary bladder cancer	0.00122	0.00124	CcSEcCtD
Doxylamine—Muscle spasms—Epirubicin—urinary bladder cancer	0.00121	0.00124	CcSEcCtD
Doxylamine—Immune system disorder—Doxorubicin—urinary bladder cancer	0.00121	0.00124	CcSEcCtD
Doxylamine—Vertigo—Methotrexate—urinary bladder cancer	0.00121	0.00124	CcSEcCtD
Doxylamine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.00121	0.00123	CcSEcCtD
Doxylamine—Leukopenia—Methotrexate—urinary bladder cancer	0.00121	0.00123	CcSEcCtD
Doxylamine—Nausea—Cisplatin—urinary bladder cancer	0.00119	0.00122	CcSEcCtD
Doxylamine—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.00117	0.00119	CcSEcCtD
Doxylamine—Convulsion—Methotrexate—urinary bladder cancer	0.00117	0.00119	CcSEcCtD
Doxylamine—Vomiting—Etoposide—urinary bladder cancer	0.00117	0.00119	CcSEcCtD
Doxylamine—Erythema—Doxorubicin—urinary bladder cancer	0.00117	0.00119	CcSEcCtD
Doxylamine—Agitation—Epirubicin—urinary bladder cancer	0.00116	0.00118	CcSEcCtD
Doxylamine—Rash—Etoposide—urinary bladder cancer	0.00116	0.00118	CcSEcCtD
Doxylamine—Dermatitis—Etoposide—urinary bladder cancer	0.00116	0.00118	CcSEcCtD
Doxylamine—Malaise—Epirubicin—urinary bladder cancer	0.00114	0.00116	CcSEcCtD
Doxylamine—Discomfort—Methotrexate—urinary bladder cancer	0.00114	0.00116	CcSEcCtD
Doxylamine—Vertigo—Epirubicin—urinary bladder cancer	0.00114	0.00116	CcSEcCtD
Doxylamine—Leukopenia—Epirubicin—urinary bladder cancer	0.00113	0.00115	CcSEcCtD
Doxylamine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.00112	0.00115	CcSEcCtD
Doxylamine—Palpitations—Epirubicin—urinary bladder cancer	0.00112	0.00114	CcSEcCtD
Doxylamine—Confusional state—Methotrexate—urinary bladder cancer	0.00111	0.00113	CcSEcCtD
Doxylamine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.0011	0.00112	CcSEcCtD
Doxylamine—Convulsion—Epirubicin—urinary bladder cancer	0.00109	0.00112	CcSEcCtD
Doxylamine—Nausea—Etoposide—urinary bladder cancer	0.00109	0.00111	CcSEcCtD
Doxylamine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.00108	0.00111	CcSEcCtD
Doxylamine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.00108	0.0011	CcSEcCtD
Doxylamine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00108	0.0011	CcSEcCtD
Doxylamine—Agitation—Doxorubicin—urinary bladder cancer	0.00107	0.00109	CcSEcCtD
Doxylamine—Anxiety—Epirubicin—urinary bladder cancer	0.00107	0.00109	CcSEcCtD
Doxylamine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00107	0.00109	CcSEcCtD
Doxylamine—Discomfort—Epirubicin—urinary bladder cancer	0.00106	0.00108	CcSEcCtD
Doxylamine—Malaise—Doxorubicin—urinary bladder cancer	0.00105	0.00107	CcSEcCtD
Doxylamine—Dry mouth—Epirubicin—urinary bladder cancer	0.00105	0.00107	CcSEcCtD
Doxylamine—Vertigo—Doxorubicin—urinary bladder cancer	0.00105	0.00107	CcSEcCtD
Doxylamine—Anorexia—Methotrexate—urinary bladder cancer	0.00105	0.00107	CcSEcCtD
Doxylamine—Leukopenia—Doxorubicin—urinary bladder cancer	0.00105	0.00107	CcSEcCtD
Doxylamine—Confusional state—Epirubicin—urinary bladder cancer	0.00104	0.00106	CcSEcCtD
Doxylamine—Palpitations—Doxorubicin—urinary bladder cancer	0.00103	0.00105	CcSEcCtD
Doxylamine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.00103	0.00105	CcSEcCtD
Doxylamine—Hypotension—Methotrexate—urinary bladder cancer	0.00103	0.00105	CcSEcCtD
Doxylamine—Convulsion—Doxorubicin—urinary bladder cancer	0.00101	0.00103	CcSEcCtD
Doxylamine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.00101	0.00103	CcSEcCtD
Doxylamine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.00101	0.00103	CcSEcCtD
Doxylamine—Tachycardia—Epirubicin—urinary bladder cancer	0.00101	0.00103	CcSEcCtD
Doxylamine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000997	0.00102	CcSEcCtD
Doxylamine—Insomnia—Methotrexate—urinary bladder cancer	0.000997	0.00102	CcSEcCtD
Doxylamine—Anxiety—Doxorubicin—urinary bladder cancer	0.000992	0.00101	CcSEcCtD
Doxylamine—Discomfort—Doxorubicin—urinary bladder cancer	0.000984	0.001	CcSEcCtD
Doxylamine—Anorexia—Epirubicin—urinary bladder cancer	0.000983	0.001	CcSEcCtD
Doxylamine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000983	0.001	CcSEcCtD
Doxylamine—Somnolence—Methotrexate—urinary bladder cancer	0.00098	0.000998	CcSEcCtD
Doxylamine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000974	0.000992	CcSEcCtD
Doxylamine—Hypotension—Epirubicin—urinary bladder cancer	0.000964	0.000982	CcSEcCtD
Doxylamine—Confusional state—Doxorubicin—urinary bladder cancer	0.000962	0.00098	CcSEcCtD
Doxylamine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000958	0.000976	CcSEcCtD
Doxylamine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000954	0.000972	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000951	0.000969	CcSEcCtD
Doxylamine—Fatigue—Methotrexate—urinary bladder cancer	0.00095	0.000968	CcSEcCtD
Doxylamine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000936	0.000953	CcSEcCtD
Doxylamine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000934	0.000952	CcSEcCtD
Doxylamine—Insomnia—Epirubicin—urinary bladder cancer	0.000933	0.00095	CcSEcCtD
Doxylamine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000931	0.000949	CcSEcCtD
Doxylamine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000923	0.00094	CcSEcCtD
Doxylamine—Dyspnoea—Epirubicin—urinary bladder cancer	0.00092	0.000937	CcSEcCtD
Doxylamine—Somnolence—Epirubicin—urinary bladder cancer	0.000917	0.000934	CcSEcCtD
Doxylamine—Anorexia—Doxorubicin—urinary bladder cancer	0.00091	0.000927	CcSEcCtD
Doxylamine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000908	0.000925	CcSEcCtD
Doxylamine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000897	0.000913	CcSEcCtD
Doxylamine—Hypotension—Doxorubicin—urinary bladder cancer	0.000892	0.000908	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.00089	0.000907	CcSEcCtD
Doxylamine—Fatigue—Epirubicin—urinary bladder cancer	0.000889	0.000906	CcSEcCtD
Doxylamine—Constipation—Epirubicin—urinary bladder cancer	0.000882	0.000899	CcSEcCtD
Doxylamine—Urticaria—Methotrexate—urinary bladder cancer	0.000876	0.000892	CcSEcCtD
Doxylamine—Insomnia—Doxorubicin—urinary bladder cancer	0.000863	0.000879	CcSEcCtD
Doxylamine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000851	0.000867	CcSEcCtD
Doxylamine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00085	0.000866	CcSEcCtD
Doxylamine—Somnolence—Doxorubicin—urinary bladder cancer	0.000848	0.000864	CcSEcCtD
Doxylamine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.00083	0.000845	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000824	0.000839	CcSEcCtD
Doxylamine—Fatigue—Doxorubicin—urinary bladder cancer	0.000823	0.000838	CcSEcCtD
Doxylamine—Urticaria—Epirubicin—urinary bladder cancer	0.000819	0.000835	CcSEcCtD
Doxylamine—Constipation—Doxorubicin—urinary bladder cancer	0.000816	0.000831	CcSEcCtD
Doxylamine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000812	0.000827	CcSEcCtD
Doxylamine—Asthenia—Methotrexate—urinary bladder cancer	0.000791	0.000806	CcSEcCtD
Doxylamine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000786	0.000801	CcSEcCtD
Doxylamine—Pruritus—Methotrexate—urinary bladder cancer	0.00078	0.000794	CcSEcCtD
Doxylamine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00076	0.000774	CcSEcCtD
Doxylamine—Urticaria—Doxorubicin—urinary bladder cancer	0.000758	0.000772	CcSEcCtD
Doxylamine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000754	0.000768	CcSEcCtD
Doxylamine—Asthenia—Epirubicin—urinary bladder cancer	0.00074	0.000754	CcSEcCtD
Doxylamine—Pruritus—Epirubicin—urinary bladder cancer	0.00073	0.000743	CcSEcCtD
Doxylamine—Dizziness—Methotrexate—urinary bladder cancer	0.000729	0.000742	CcSEcCtD
Doxylamine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000706	0.000719	CcSEcCtD
Doxylamine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000703	0.000716	CcSEcCtD
Doxylamine—Vomiting—Methotrexate—urinary bladder cancer	0.000701	0.000714	CcSEcCtD
Doxylamine—Rash—Methotrexate—urinary bladder cancer	0.000695	0.000708	CcSEcCtD
Doxylamine—Dermatitis—Methotrexate—urinary bladder cancer	0.000694	0.000707	CcSEcCtD
Doxylamine—Asthenia—Doxorubicin—urinary bladder cancer	0.000685	0.000698	CcSEcCtD
Doxylamine—Dizziness—Epirubicin—urinary bladder cancer	0.000682	0.000695	CcSEcCtD
Doxylamine—Pruritus—Doxorubicin—urinary bladder cancer	0.000675	0.000688	CcSEcCtD
Doxylamine—Vomiting—Epirubicin—urinary bladder cancer	0.000656	0.000668	CcSEcCtD
Doxylamine—Nausea—Methotrexate—urinary bladder cancer	0.000655	0.000667	CcSEcCtD
Doxylamine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000653	0.000665	CcSEcCtD
Doxylamine—Rash—Epirubicin—urinary bladder cancer	0.00065	0.000663	CcSEcCtD
Doxylamine—Dermatitis—Epirubicin—urinary bladder cancer	0.00065	0.000662	CcSEcCtD
Doxylamine—Dizziness—Doxorubicin—urinary bladder cancer	0.000631	0.000643	CcSEcCtD
Doxylamine—Nausea—Epirubicin—urinary bladder cancer	0.000613	0.000624	CcSEcCtD
Doxylamine—Vomiting—Doxorubicin—urinary bladder cancer	0.000607	0.000618	CcSEcCtD
Doxylamine—Rash—Doxorubicin—urinary bladder cancer	0.000602	0.000613	CcSEcCtD
Doxylamine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000601	0.000612	CcSEcCtD
Doxylamine—Nausea—Doxorubicin—urinary bladder cancer	0.000567	0.000577	CcSEcCtD
